GILD

Gilead Sciences, Inc.

68.06 USD
+4.91 (+7.78%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Gilead Sciences, Inc. stock is up 1.14% since 30 days ago. The next earnings date is Aug 1, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 64.52% of the previous 30 June’s closed higher than May. In the last 10 Unusual Options Trades, there were 9 CALLs, 1 PUT. 0% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
20 Jun 16:43 16 Aug, 2024 77.50 CALL 500 1400
20 Jun 16:49 21 Jun, 2024 68.00 CALL 470 528
20 Jun 16:55 19 Jul, 2024 70.00 CALL 226 3070
20 Jun 16:55 21 Jun, 2024 65.00 CALL 226 3126
20 Jun 16:56 21 Jun, 2024 66.00 CALL 157 1485
20 Jun 16:56 21 Jun, 2024 66.00 CALL 155 1485
20 Jun 17:11 21 Jun, 2024 66.00 CALL 94 1485
20 Jun 17:24 19 Jul, 2024 67.50 PUT 1279 730
20 Jun 17:56 19 Jul, 2024 70.00 CALL 795 3070
20 Jun 18:19 16 Aug, 2024 70.00 CALL 200 4582

About Gilead Sciences, Inc.

Gilead Sciences discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, and Atripla products for the treatment of HIV/AIDS.